Evidence map›Paper›PMID 35923133›Full record

ArticlePhysiological reports2022

Rats with high aerobic capacity display enhanced transcriptional adaptability and upregulation of bile acid metabolism in response to an acute high-fat diet.

Harrison D Stierwalt, E Matthew Morris, Adrianna Maurer, Udayan Apte, Kathryn Phillips, Tiangang Li, Grace M E Meers, Lauren G Koch, Steven L Britton, Greg Graf and 4 more

Open access · goldAbstract read
In one paragraph

Article in Physiological reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 10 institutions in 2 countries.

Harrison D StierwaltMolecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Missouri, USA.
E Matthew MorrisMolecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Missouri, USA.
Adrianna MaurerMolecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Missouri, USA.
Udayan ApteDepartment of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, Kansas City, Missouri, USA.
Kathryn PhillipsDepartment of Pediatrics, Cornell Medicine, New York, New York, USA.
Tiangang LiDepartment of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, USA.
Grace M E MeersDivision of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA.
Lauren G KochPhysiology and Pharmacology, The University of Toledo, Toledo, Ohio, USA.ORCID 0000-0002-2019-5939
Steven L BrittonAnesthesiology, University of Michigan, Ann Arbor, Michigan, USA.
Greg GrafDepartment of Pharmaceutical Sciences, Saha Cardiovascular Research Center, University of Kentucky, Lexington, Kentucky, USA.
R Scott RectorDivision of Gastroenterology and Hepatology, University of Missouri, Columbia, Missouri, USA.
Kelly MercerArkansas Children's Nutrition Center, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
Kartik ShankarSection of Nutrition, Department of Pediatrics, University of Colorado School of Medicine Anschutz Medical Campus, Aurora, Colorado, USA.
John P ThyfaultMolecular and Integrative Physiology, University of Kansas Medical Center, Kansas City, Missouri, USA.ORCID 0000-0001-7920-7466
University of Kansas Medical Center · USArkansas Children's Hospital · USHarry S. Truman Memorial Veterans' Hospital · USNewYork–Presbyterian Hospital · USNutrition Sciences (Belgium) · BEUniversity of Colorado Anschutz Medical Campus · USUniversity of Kentucky · USUniversity of Michigan · USUniversity of Oklahoma Health Sciences Center · USUniversity of Toledo · US

Funding

WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
Contributions of Hepatic and Intestinal Pathways to Cholesterol ExcretionR01DK113625 · NIDDK · UNIVERSITY OF KENTUCKY · PI Gregory A Graf · 2017 to 2026
$4.2M
Statins: Mitochondrial Function and Aerobic CapacityR01AR071263 · NIAMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI NEUFER, P DARRELL, THYFAULT, JOHN P · 2017 to 2021
$3.0M
Regulation of Bile Acid Metabolism and Signaling in Metabolic DiseasesR01DK117965 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Tiangang Li · 2019 to 2026
$2.7M
Exercise &Health: Integration from Molecule to PatientT32AR048523 · NIAMS · UNIVERSITY OF MISSOURI-COLUMBIA · PI TERJUNG, RONALD L · 2003 to 2013
$2.5M
Divergence in Aerobic Capacity Drives Liver and Brain HealthR01DK121497 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI THYFAULT, JOHN P · 2019 to 2022
$2.2M
Resource for Rat Genetic Models of Aerobic CapacityP40OD021331 · OD · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI KOCH, LAUREN GERARD · 2015 to 2019
$1.9M
Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic FlexibilityR01DK131064 · NIDDK · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI LI, TIANGANG · 2022 to 2025
$1.6M
Aerobic fitness, mitochondrial dysfunction, and fatty liver diseaseR01DK088940 · NIDDK · UNIVERSITY OF MISSOURI-COLUMBIA · PI THYFAULT, JOHN P · 2011 to 2015
$1.5M
Exercise induced regulation of CYP7a1 and bile acid metabolismF32DK130244 · NIDDK · UNIVERSITY OF KANSAS MEDICAL CENTER · PI STIERWALT, HARRISON DANIEL · 2021 to 2021
$27k
Sexual dimorphism, hepatic mitochondrial adaptations, and hepatic steatosisI01BX002567 · VA · KANSAS CITY VA MEDICAL CENTER · PI THYFAULT, JOHN P · 2015 to 2025
–
BLRD VA I01 BX002567NIAMS NIH HHS R01 AR071263NIAMS NIH HHS T32 AR048523NIDDK NIH HHS F32DK130244NIDDK NIH HHS R01 DK088940NIDDK NIH HHS R01 DK121497NIH HHS P40 OD021331
6 · The paper itself

Abstract

Rats selectively bred for the high intrinsic aerobic capacity runner (HCR) or low aerobic capacity runner (LCR) show pronounced differences in susceptibility for high-fat/high sucrose (HFHS) diet-induced hepatic steatosis and insulin resistance, replicating the protective effect of high aerobic capacity in humans. We have previously shown multiple systemic differences in energy and substrate metabolism that impacts steatosis between HCR and LCR rats. This study aimed to investigate hepatic-specific mechanisms of action via changes in gene transcription. Livers of HCR rats had a greater number of genes that significantly changed in response to 3-day HFHS compared with LCR rats (171 vs. 75 genes: >1.5-fold, p < 0.05). HCR and LCR rats displayed numerous baseline differences in gene expression while on a low-fat control diet (CON). A 3-day HFHS diet resulted in greater expression of genes involved in the conversion of excess acetyl-CoA to cholesterol and bile acid (BA) synthesis compared with the CON diet in HCR, but not LCR rats. These results were associated with higher fecal BA loss and lower serum BA concentrations in HCR rats. Exercise studies in rats and mice also revealed higher hepatic expression of cholesterol and BA synthesis genes. Overall, these results suggest that high aerobic capacity and exercise are associated with upregulated BA synthesis paired with greater fecal excretion of cholesterol and BA, an effect that may play a role in protection against hepatic steatosis in rodents.

Indexed as

Diet, High-FatFatty LiverAnimalsBile Acids and SaltsCholesterolHumansLipid MetabolismMiceRatsUp-RegulationBile Acids and SaltsCholesterolaerobic capacitybile acidscholesterolfatty liver

Identifiers

PMID35923133
PMCPMC9350427
OpenAlexW4289732085

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.